{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:18:11Z","timestamp":1790432291542,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["27-2"],"award-info":[{"award-number":["27-2"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["29-16"],"award-info":[{"award-number":["29-16"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neures.2018.09.016","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T12:29:30Z","timestamp":1537792170000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid"],"prefix":"10.1016","volume":"139","author":[{"given":"Yuriko","family":"Tatsumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Iibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-9596","authenticated-orcid":false,"given":"Kazunori","family":"Sango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neures.2018.09.016_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015351","article-title":"Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling","volume":"5","author":"BasuRay","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neures.2018.09.016_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/glia.20386","article-title":"Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease)","volume":"54","author":"Berger","year":"2006","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.neures.2018.09.016_bib0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/1873-3468.12962","article-title":"The role of tRNA synthetases in neurological and neuromuscular disorders","volume":"592","author":"Boczonadi","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neures.2018.09.016_bib0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01064","article-title":"Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function","volume":"2","author":"Cherry","year":"2013","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.neures.2018.09.016_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2008.05.060","article-title":"Characterization of the Rab7K157N mutant protein associated with Charcot-Marie-Tooth type 2B","volume":"372","author":"De Luca","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2018.09.016_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajhg.2009.12.005","article-title":"A major determinant for binding and aminoacylation of tRNA-Ala in cytoplasmic alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth Disease","volume":"86","author":"Latour","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neures.2018.09.016_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10048-009-0183-3","article-title":"Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models","volume":"10","author":"Leal","year":"2009","journal-title":"Neurogenetics"},{"issue":"12","key":"10.1016\/j.neures.2018.09.016_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029393","article-title":"The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neures.2018.09.016_bib0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/hmg\/ddp567","article-title":"Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation","volume":"19","author":"McCray","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"265","key":"10.1016\/j.neures.2018.09.016_bib0050","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003661","article-title":"Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons","volume":"6","author":"Miyamoto","year":"2013","journal-title":"Sci. Signal."},{"issue":"13478","key":"10.1016\/j.neures.2018.09.016_bib0055","article-title":"VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination","volume":"7","author":"Miyamoto","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neures.2018.09.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar4471","article-title":"BIG1\/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann cells in mice","volume":"4","author":"Miyamoto","year":"2018","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.neures.2018.09.016_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/dneu.22581","article-title":"Searching for the gut microbial contributing factors to social behavior in rodent models of autism spectrum disorder","volume":"78","author":"Needham","year":"2018","journal-title":"Dev. Neurobiol."},{"issue":"5","key":"10.1016\/j.neures.2018.09.016_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/WCO.0000000000000373","article-title":"Recent advances in the genetic neuropathies","volume":"29","author":"Rossor","year":"2016","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.neures.2018.09.016_bib0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/bies.201600052","article-title":"Peripheral neuropathy via mutant tRNA synthetases: inhibition of protein translation provides a possible explanation","volume":"38","author":"Storkebaum","year":"2016","journal-title":"Bioessays"},{"issue":"7","key":"10.1016\/j.neures.2018.09.016_bib0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/jcp.25261","article-title":"Rab, Arf, and Arl-regulated membrane traffic in cortical neuron migration","volume":"231","author":"Tang","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.neures.2018.09.016_bib0085","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/367847","article-title":"Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy","volume":"72","author":"Verhoeven","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.neures.2018.09.016_bib0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","article-title":"The JNK signal transduction pathway","volume":"19","author":"Weston","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"issue":"15","key":"10.1016\/j.neures.2018.09.016_bib0095","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.yexcr.2006.05.016","article-title":"JNK phosphorylation of paxillin, acting through the Rac1 and Cdc42 signaling cascade, mediates neurite extension in N1E-115 cells","volume":"312","author":"Yamauchi","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.neures.2018.09.016_bib0100","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.yexcr.2007.02.019","article-title":"Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells","volume":"313","author":"Yamauchi","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"11-12","key":"10.1016\/j.neures.2018.09.016_bib0105","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.yexcr.2008.03.019","article-title":"Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin","volume":"314","author":"Yamauchi","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"14","key":"10.1016\/j.neures.2018.09.016_bib0110","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/jnr.22460","article-title":"The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway","volume":"88","author":"Yamauchi","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"243","key":"10.1016\/j.neures.2018.09.016_bib0115","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002802","article-title":"Phosphorylation of cytohesin-1 by Fyn is required for initiation of myelination and the extent of myelination during development","volume":"5","author":"Yamauchi","year":"2012","journal-title":"Sci. Signal."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016801021830542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016801021830542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:25:56Z","timestamp":1759141556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016801021830542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"alternative-id":["S016801021830542X"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2018.09.016","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2018.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}